针对胆酸代谢:营养和微生物方法来缓解性结肠炎
Xiaoxin Jiang1, Jingyi Ren1, Gejun Yu1
1School of Public Health, Health Science Center, Ningbo University, Ningbo 315211, China.
Nutrients
|April 12, 2025
概括
性结肠炎 (UC) 涉及肠道微生物群和胆酸 (BAs). 调节BA代谢和微生物群为管理这种慢性炎症疾病提供了一个有希望的治疗策略.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 性结肠炎 (UC) 是结肠直肠的慢性炎症状况,具有重大的全球健康影响.
- 新兴的研究强调了肠道微生物群及其代谢物,特别是胆酸 (BAs) 在UC病变发生过程中的关键作用.
研究的目的:
- 审查胆汁酸 (BAs) 的分类,合成和代谢.
- 探索肠道微生物群和BA之间的复杂的双向关系.
- 检查针对BA代谢和肠道微生物群的治疗潜力,以治疗性结肠炎 (UC).
主要方法:
- 文献综述侧重于胆酸代谢,肠道微生物群相互作用和治疗干预措施.
- 对Farnesoid X受体 (FXR) 和Takeda G蛋白结合受体5 (TGR5) 在调解BA-微生物群交叉中的作用的分析.
- 对调节UC肠道环境的营养和微生物策略的评估.
主要成果:
- 胆酸 (BAs) 和肠道微生物群表现出相互关系,影响彼此的组成和活性.
- BA通过特定的受体,如FXR和TGR5.5,来调节微生物群.
- 营养和微生物干预措施显示出重塑肠道微生物群和管理UC的潜力.
结论:
- 胆汁酸 (BAs) 和肠道微生物群之间的相互作用是性结肠炎 (UC) 病原体的核心.
- 准胆汁酸代谢是UC的一种有前途的治疗途径.
- 对营养和微生物疗法的进一步研究可以为UC治疗提供创新的方法.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
107
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
107
Peptic Ulcer Disease IV: Management
51
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
51
Inflammatory Bowel Disease I: Ulcerative Colitis
98
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
98
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
251
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
251
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80
Inflammatory Bowel Disease V: Surgical Management
67
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
67


